Latest News
-
Gold Prices Ayodhya: In Ram-Janma-Bhumi, 24carat Falls By Rs 380 In 10-Grams, Drops By Rs 3,800 In 100-gram -
Penny Stock Hits 2nd Upper Circuit After Declaring Earnings, Gains 14% In 1-Week -
Rs 8.50/Share Dividend Recommended: Nestle India Reports 27% YoY Jump In Profit -
0.50% Dividend Yield: Midcap Cement Stock Slumps 10% Following Weak Q4 Results; Profit Down 48% YoY -
1:10 Split, Rs 147/Share Dividend: FMCG Major Likely To Report Profit Growth; Buy Or Sell? -
Mark Zuckerberg's Meta Reports Record Q1 Profit Surge, Projects AI Investments This Year; Stock Slumps -
Gold Prices India: 24K/100 Grams Yellow Metal Falls By Rs 3800, 24K/10 Grams Down By Rs 380 -
Rs 44,000 Crore M-Cap Lost, Stock Falls 10%, No More 4th Largest Bank; How RBI's Ban Rocked Kotak -
Mukesh Ambani Led JioCinema Slashes Premium Subscription Prices; IPL Live Stream Remains Free -
Strong Listing: Vodafone Idea FPO Soars In Debut, Shares Rebound; KM Birla Lauds Success
For Daily Alerts
Pharma stocks rally in listless trading
Pharma stocks were in the limelight in an otherwise lacklustre trading session with Glenmark Pharma rallying 3.24 per cent, Sun Pharma jumping 2 per cent, Piramal Enter rallying one per cent and Dr Reddy's gaining 0.80 per cent.
Other gainers from the sector were Cipla, Ranbaxy Laboratories and Lupin. Analysts attribute the gains in pharma stocks to renewed investor interest following better growth prospects and also hedging against any likely fall in the markets.
Pharma stocks are defensive stocks and hence do not fall, during a sharp decline in the markets.
GoodReturns.in
More From GoodReturns
